Pharmacologic options for the treatment and management of food allergy

Expert Review of Clinical Pharmacology

Volumn 8, Issue 5, 2015, Pages 623-633

  Kobernick, Aaron K ^a   Chambliss, Jeffrey ^a   Burks, A Wesley ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant; Allergy; Anaphylaxis; Egg; Epicutaneous; Food; Immunotherapy; Milk; Multifood; Omalizumab; Oral; Peanut; Probiotic; Sublingual

Indexed keywords

ADJUVANT; ALLERGEN; OMALIZUMAB; RECOMBINANT VACCINE; ADRENALIN; ANTIHISTAMINIC AGENT; HERBACEOUS AGENT;

CHINESE HERB; DESENSITIZATION; EGG; EGG ORAL IMMUNOTHERAPY; EPICUTANEOUS IMMUNOTHERAPY; FOOD ALLERGY; HUMAN; IMMUNOTHERAPY; MILK; MILK ORAL IMMUNOTHERAPY; MILK SUBLINGUAL IMMUNOTHERAPY; MULTICENTER STUDY (TOPIC); MULTIFOOD ORAL IMMUNOTHERAPY; NONHUMAN; ORAL IMMUNOTHERAPY; PEANUT; PEANUT ORAL IMMUNOTHERAPY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; ADULT; ADVERSE EFFECTS; ANIMAL; CHILD; FOOD HYPERSENSITIVITY; IMMUNOLOGY; PROCEDURES;

ADULT; ALLERGENS; ANIMALS; CHILD; DRUGS, CHINESE HERBAL; EPINEPHRINE; FOOD HYPERSENSITIVITY; HISTAMINE ANTAGONISTS; HUMANS; IMMUNOTHERAPY;

EID: 84940614844     PISSN: 17512433     EISSN: 17512441     Source Type: Journal    
DOI: 10.1586/17512433.2015.1074038     Document Type: Review

References (111)

1. Kamdar TA, Peterson S, Lau CH, et al. Prevalence and characteristics of adult-onset food allergy. J Allergy Clin Immunol Pract 2015; 3(1): 114-15
2. Dyer AA, Gupta R. Epidemiology of childhood food allergy. Pediatr Ann 2013; 42(6): 91-5
3. Sicherer SH, Sampson HA. Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol 2014; 133(2): 291-307. quiz 8
4. Osborne NJ, Koplin JJ, Martin PE, et al. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol 2011; 127(3): 668-76
5. Gupta RS, Lau CH, Dyer AA, et al. Food allergy diagnosis and management practices among pediatricians. Clin Pediatr (Phila) 2014; 53(6): 524-30
6. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics 2009; 124(6): 1549-55
7. Sampson HA, Aceves S, Bock SA, et al. Food allergy: A practice parameter update-2014. J Allergy Clin Immunol 2014; 134(5): 1016-25 e43
8. Bock SA, Atkins FM. The natural history of peanut allergy. J Allergy Clin Immunol 1989; 83(5): 900-4
9. Vander Leek TK, Liu AH, Stefanski K, et al. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr 2000; 137(6): 749-55
10. Chad L, Ben-Shoshan M, Asai Y, et al. A majority of parents of children with peanut allergy fear using the epinephrine auto-injector. Allergy 2013; 68(12): 1605-9
11. Primeau MN, Kagan R, Joseph L, et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 2000; 30(8): 1135-43
12. Nelson HS, Lahr J, Rule R, et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99(6 Pt 1): 744-51
13. Oppenheimer JJ, Nelson HS, Bock SA, et al. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992; 90(2): 256-62
14. Zuidmeer-Jongejan L, Fernandez-Rivas M, Poulsen LK, et al. FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies. Clin Transl Allergy 2012; 2(1): 5
15. Kulis M, Vickery BP, Burks AW. Pioneering immunotherapy for food allergy: clinical outcomes and modulation of the immune response. Immunol Res 2011; 49(1-3): 216-26
16. Thyagarajan A, Jones SM, Calatroni A, et al. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy 2012; 42(8): 1197-205
17. Fuentes-Aparicio V, Alonso-Lebrero E, Zapatero L, et al. Induction of Treg cells after oral immunotherapy in hen's egg-allergic children. Pediatr Allergy Immunol 2014; 25(1): 103-6
18. Reber LL, Marichal T, Mukai K, et al. Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice. J Allergy Clin Immunol 2013; 132(4): 881-8. e1-11
19. Hoh RA, Joshi SA, Liu Y, et al. Single B-cell deconvolution of peanut-specific antibody responses in allergic patients. J Allergy Clin Immunol 2015. [Epub ahead of print]
20. Anagnostou K, Islam S, King Y, et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): A phase 2 randomised controlled trial. Lancet 2014; 383(9925): 1297-304
21. Calatayud CM, Garca AM, Aragones AM, Caballer BeL. Safety and efficacy profile and immunological changes associated with oral immunotherapy for IgE-mediated cow's milk allergy in children: systematic review and meta-analysis. J Investig Allergol Clin Immunol 2014; 24(5): 298-307
22. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012; 129(2): 448-55
23. Lucendo AJ, Arias A, Tenias JM. Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: A systematic review with meta-analysis. Ann Allergy Asthma Immunol 2014; 113(6): 624-9
24. Patriarca G, Schiavino D, Nucera E, et al. Food allergy in children: results of a standardized protocol for oral desensitization. Hepatogastroenterology 1998; 45(19): 52-8
25. Nurmatov U, Venderbosch I, Devereux G, et al. Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst Rev 2012; 9: CD009014
26. Jones SM, Pons L, Roberts JL, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009; 124(2): 292-300
27. Varshney P, Jones SM, Scurlock AM, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011; 127(3): 654-60
28. Vickery BP, Scurlock AM, Kulis M, et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 2014; 133(2): 468-75
29. Bird JA, Feldman M, Arneson A, et al. Modified peanut oral immunotherapy protocol safely and effectively induces desensitization. J Allergy Clin Immunol Pract 2015. [Epub ahead of print]
30. Tang ML, Ponsonby AL, Orsini F, et al. Administration of a probiotic with peanut oral immunotherapy: A randomized trial. J Allergy Clin Immunol 2015; 135(3): 737-44
31. Plundrich NJ, Kulis M, White BL, et al. Novel strategy to create hypoallergenic peanut protein-polyphenol edible matrices for oral immunotherapy. J Agric Food Chem 2014; 62(29): 7010-21
32. Burks AW, Jones SM, Wood RA, et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012; 367(3): 233-43
33. Caminiti L, Pajno GB, Crisafulli G, et al. Oral Immunotherapy for Egg Allergy: A Double-Blind Placebo-Controlled Study, with Postdesensitization Follow-Up. J Allergy Clin Immunol Pract 2015; Epub ahead of print
34. Meglio P, Giampietro PG, Carello R, et al. Oral food desensitization in children with IgE-mediated hen's egg allergy: A new protocol with raw hen's egg. Pediatr Allergy Immunol 2013; 24(1): 75-83
35. Sudo K, Taniuchi S, Takahashi M, et al. Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy. Allergy Asthma Clin Immunol 2014; 10(1): 11
36. Itoh N, Itagaki Y, Kurihara K. Rush specific oral tolerance induction in school-age children with severe egg allergy: one year follow up. Allergol Int 2010; 59(1): 43-51
37. Garca Rodrguez R, Urra JM, Feo-Brito F, et al. Oral rush desensitization to egg: efficacy and safety. Clin Exp Allergy 2011; 41(9): 1289-96
38. Turner PJ, Mehr S, Joshi P, et al. Safety of food challenges to extensively heated egg in egg-allergic children: A prospective cohort study. Pediatr Allergy Immunol 2013; 24(5): 450-5
39. Leonard SA, Sampson HA, Sicherer SH, et al. Dietary baked egg accelerates resolution of egg allergy in children. J Allergy Clin Immunol 2012; 130(2): 473-80. e1
40. Lee E, Mehr S, Turner PJ, et al. Adherence to extensively heated egg and cow's milk after successful oral food challenge. J Allergy Clin Immunol Pract 2015; 3(1): 125-7. e4
41. Dhanapala P, Doran T, Tang ML, Suphioglu C. Production and immunological analysis of IgE reactive recombinant egg white allergens expressed in Escherichia coli. Mol Immunol 2015; 65(1): 104-12
42. Vazquez-Ortiz M, Alvaro M, Piquer M, et al. Impact of oral immunotherapy on quality of life in egg allergic children. Pediatr Allergy Immunol 2015; Epub ahead of print
43. Vazquez-Ortiz M, Alvaro M, Piquer M, et al. Life-threatening anaphylaxis to egg and milk oral immunotherapy in asthmatic teenagers. Ann Allergy Asthma Immunol 2014; 113(4): 482-4
44. Vickery BP, Pons L, Kulis M, et al. Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol 2010; 105(6): 444-50
45. Vazquez-Ortiz M, Alvaro M, Piquer M, et al. Baseline specific IgE levels are useful to predict safety of oral immunotherapy in egg-allergic children. Clin Exp Allergy 2014; 44(1): 130-41
46. Lee JH, Kim WS, Kim H, Hahn YS. Increased cow's milk protein-specific IgG4 levels after oral desensitization in 7-to 12-month-old infants. Ann Allergy Asthma Immunol 2013; 111(6): 523-8
47. Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008; 121(2): 343-7
48. Pajno GB, Caminiti L, Ruggeri P, et al. Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: A randomized single-blind controlled study. Ann Allergy Asthma Immunol 2010; 105(5): 376-81
49. Martorell A, De la Hoz B, Ibáñez MD, et al. Oral desensitization as a useful treatment in 2-year-old children with cow's milk allergy. Clin Exp Allergy 2011; 41(9): 1297-304
50. Skripak JM, Nash SD, Rowley H, et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008; 122(6): 1154-60
51. Sánchez-Garca S, Rodrguez del Ro P, Escudero C, et al. Efficacy of oral immunotherapy protocol for specific oral tolerance induction in children with cow's milk allergy. Isr Med Assoc J 2012; 14(1): 43-7
52. Vázquez-Ortiz M, Alvaro-Lozano M, Alsina L, et al. Safety and predictors of adverse events during oral immunotherapy for milk allergy: severity of reaction at oral challenge, specific IgE and prick test. Clin Exp Allergy 2013; 43(1): 92-102
53. Garca-Ara C, Pedrosa M, Belver MT, et al. Efficacy and safety of oral desensitization in children with cow's milk allergy according to their serum specific IgE level. Ann Allergy Asthma Immunol 2013; 110(4): 290-4
54. Levy MB, Elizur A, Goldberg MR, et al. Clinical predictors for favorable outcomes in an oral immunotherapy program for IgE-mediated cow's milk allergy. Ann Allergy Asthma Immunol 2014; 112(1): 58-63
55. Savilahti EM, Kuitunen M, Savilahti E, Mäkelä MJ. Specific antibodies in oral immunotherapy for cow's milk allergy: kinetics and prediction of clinical outcome. Int Arch Allergy Immunol 2014; 164(1): 32-9
56. Keet CA, Seopaul S, Knorr S, et al. Long-term follow-up of oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2013; 132(3): 737-9
57. Martnez-Botas J, Rodrguez M, Cerecedo I, et al. Identification of novel peptide biomarkers to predict safety and efficacy of Cow's Milk Oral Immunotherapy by peptide microarray. Clin Exp Allergy 2015; Epub ahead of print
58. Mehr S, Turner PJ, Joshi P, et al. Safety and clinical predictors of reacting to extensively heated cow's milk challenge in cow's milk-allergic children. Ann Allergy Asthma Immunol 2014; 113(4): 425-9
59. Begin P, Winterroth LC, Dominguez T, et al. Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol 2014; 10(1): 1
60. Begin P, Dominguez T, Wilson SP, et al. Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab. Allergy Asthma Clin Immunol 2014; 10(1): 7
61. Schneider LC, Rachid R, LeBovidge J, et al. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. J Allergy Clin Immunol 2013; 132(6): 1368-74
62. Nadeau KC, Schneider LC, Hoyte L, et al. Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol 2011; 127(6): 1622-4
63. Wasserman RL, Factor JM, Baker JW, et al. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. J Allergy Clin Immunol Pract 2014; 2(1): 91-6
64. Varshney P, Steele PH, Vickery BP, et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009; 124(6): 1351-2
65. Hofmann AM, Scurlock AM, Jones SM, et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009; 124(2): 286-91
66. Kulis M, Saba K, Kim EH, et al. Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. J Allergy Clin Immunol 2012; 129(4): 1159-62
67. Burks AW, Wood RA, Jones SM, et al. Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol 2015; Epub ahead of print
68. Fleischer DM, Burks AW, Vickery BP, et al. Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 2013; 131(1): 119-27
69. Chin SJ, Vickery BP, Kulis MD, et al. Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison. J Allergy Clin Immunol 2013; 132(2): 476-8
70. Narisety SD, Frischmeyer-Guerrerio PA, Keet CA, et al. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol 2014; Epub ahead of print
71. de Boissieu D, Dupont C. Sublingual immunotherapy for cow's milk protein allergy: A preliminary report. Allergy 2006; 61(10): 1238-9
72. Dioszeghy V, Mondoulet L, Dhelft V, et al. The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice. Clin Exp Allergy 2014; 44(6): 867-81
73. Dioszeghy V, Mondoulet L, Dhelft V, et al. Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice. J Immunol 2011; 186(10): 5629-37
74. Mondoulet L, Dioszeghy V, Vanoirbeek JA, et al. Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts. Int Arch Allergy Immunol 2011; 154(4): 299-309
75. Mondoulet L, Dioszeghy V, Larcher T, et al. Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice. PLoS ONE 2012; 7(2): e31967
76. Mondoulet L, Dioszeghy V, Ligouis M, et al. Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense). ISRN Allergy 2012; 2012: 375735
77. Mondoulet L, Dioszeghy V, Puteaux E, et al. Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model. J Allergy Clin Immunol 2015; Epub ahead of print
78. Dupont C, Kalach N, Soulaines P, et al. Cow's milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 2010; 125(5): 1165-7
79. Wood RA, Sicherer SH, Burks AW, et al. A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy 2013; 68(6): 803-8
80. Smaldini PL, Ibañez AE, Fossati CA, et al. Oral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergy. Hum Vaccin Immunother 2014; 10(7): 2015-23
81. Li XM, Zhang TF, Huang CK, et al. Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol 2001; 108(4): 639-46
82. Qu C, Srivastava K, Ko J, et al. Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-gamma. Clin Exp Allergy 2007; 37(6): 846-55
83. Srivastava KD, Kattan JD, Zou ZM, et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol 2005; 115(1): 171-8
84. Wang J, Patil SP, Yang N, et al. Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: A randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study. Ann Allergy Asthma Immunol 2010; 105(1): 75-84
85. Patil SP, Wang J, Song Y, et al. Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study. J Allergy Clin Immunol 2011; 128(6): 1259-65. e2
86. Lisann L, Song Y, Wang J, et al. Successful prevention of extremely frequent and severe food anaphylaxis in three children by combined traditional Chinese medicine therapy. Allergy Asthma Clin Immunol 2014; 10(1): 66
87. Yang N, Wang J, Liu C, et al. Berberine and limonin suppress IgE production by human B cells and peripheral blood mononuclear cells from food-allergic patients. Ann Allergy Asthma Immunol 2014; 113(5): 556-64. e4
88. Albin S, Nowak-Wegrzyn A. Potential treatments for food allergy. Immunol Allergy Clin North Am 2015; 35(1): 77-100
89. Keet CA, Wood RA. Emerging therapies for food allergy. J Clin Invest 2014; 124(5): 1880-6
90. Burton OT, Logsdon SL, Zhou JS, et al. Oral immunotherapy induces IgG antibodies that act through FcgRIIb to suppress IgE-mediated hypersensitivity. J Allergy Clin Immunol 2014; 134(6): 1310-17. e6
91. Hsieh FH. Oral food immunotherapy and iatrogenic eosinophilic esophagitis: An acceptable level of risk? Ann Allergy Asthma Immunol 2014; 113(6): 581-2
92. Nozawa A, Okamoto Y, Moverare R, et al. Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy. Pediatr Allergy Immunol 2014; 25(4): 323-8
93. Simons E. Assessing the Efficacy of Oral Immunotherapy for the Desensitisation of Peanut Allergy in Children (STOP II): A Phase 2 Randomised Controlled Trial. Pediatrics 2014; 134(Suppl 3): S155-6
94. Still LM, Jones SM. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. Pediatrics 2014; 134(Suppl 3): S155
95. Sun J, Hui X, Ying W, et al. Efficacy of allergen-specific immunotherapy for peanut allergy: A meta-analysis of randomized controlled trials. Allergy Asthma Proc 2014; 35(2): 171-7
96. Vickery BP, Lin J, Kulis M, et al. Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol 2013; 131(1): 128-34
97. Yu GP, Weldon B, Neale-May S, Nadeau KC. The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial. Int Arch Allergy Immunol 2012; 159(2): 179-82
98. Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for IgE-mediated cow's milk allergy: A systematic review and meta-analysis. Clin Exp Allergy 2012; 42(3): 363-74
99. Carraro S, Frigo AC, Perin M, et al. Impact of oral immunotherapy on quality of life in children with cow milk allergy: A pilot study. Int J Immunopathol Pharmacol 2012; 25(3): 793-8
100. Factor JM, Mendelson L, Lee J, et al. Effect of oral immunotherapy to peanut on food-specific quality of life. Ann Allergy Asthma Immunol 2012; 109(5): 348-52
101. Gorelik M, Narisety SD, Guerrerio AL, et al. Suppression of the immunologic response to peanut during immunotherapy is often transient. J Allergy Clin Immunol 2014; Epub ahead of print
102. Huang F, Nowak-Wegrzyn A. Extensively heated milk and egg as oral immunotherapy. Curr Opin Allergy Clin Immunol 2012; 12(3): 283-92
103. Kulis M, Wesley Burks A. Oral immunotherapy for food allergy: clinical and preclinical studies. Adv Drug Deliv Rev 2013; 65(6): 774-81
104. Lomas JM, Bingemann TA. Clinical Predictors for Favorable Outcomes in an Oral Immunotherapy Program for IgE-Mediated Cow's Milk Allergy. Pediatrics 2014; 134(Suppl 3): S156
105. Martorell-Aragones A, Echeverra-Zudaire L, Alonso-Lebrero E, et al. Position document: IgE-mediated cow's milk allergy. Allergol Immunopathol (Madr) 2015; Epub ahead of print
106. Narisety SD, Skripak JM, Steele P, et al. Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2009; 124(3): 610-12
107. Okamoto Y, Kurihara K. (A case of eosinophilic esophagogastroenteritis which developed after rush oral immunotherapy for egg allergy). Arerugi 2015; 64(1): 57-62
108. Rodrguez CG, Torrijos EG, De la Pinzon FR, et al. Dysphagia in a boy treated with oral immunotherapy for cow's milk allergy. J Investig Allergol Clin Immunol 2014; 24(5): 363-5
109. Santos AF, James LK, Bahnson HT, et al. IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens. J Allergy Clin Immunol 2015; Epub ahead of print
110. Syed A, Garcia MA, Lyu SC, et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol 2014; 133(2): 500-10
111. Kim EH, Bird JA, Kulis M, et al. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol 2011; 127(3): 640-6